BHC · Bausch Health Companies Inc
United States · RS rating 96 · As of 2026-11-03
| Price | 8.14 USD |
|---|---|
| 1-day change | +1.5% |
| RS rating (overall / 1M / 3M / 12M) | 96 / 97 / 92 / 65 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 46 / 51 / 47 |
| Industry group (rank) | Medical-Ethical Drugs (94) |
| EPS growth Q/Q | -162.5% |
| Sales growth Q/Q | +4.3% |
| Distance from 52-week high | +8.6% |
| Market cap (USD) | $2.1B |